Vice President of Fudan University Cancer Hospital, the leading expert in urology, the chief expert of the urological oncology MDT, the director of the Shanghai Institute of Urological Oncology, and the director of the Fudan University Prostate Cancer Institute
Affiliated HospitalFudan University Cancer Hospital
→
He is also the Executive Director of the Chinese Anti-Cancer Association Integrated Prostate Oncology Committee, the Vice Chairman of the Chinese Anti-Cancer Association Integrated Urological Oncology Committee, the Chairman of the Chinese Anti-Cancer Association Male Reproductive System Tumor Committee (CACA-GO), the Chairman of the Prostate Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Chairman of the Urology Committee of the China Primary Health Care Foundation, the former Chairman of the Chinese Anti-Cancer Association Urogenital Tumor Committee (CACA-GU), the Deputy Leader of the Oncology Group of the Chinese Urological Association (CUA), and the Chairman of the CPCC. With nearly 40 years of experience in medical practice, teaching, and research, he founded and led the largest urological oncology diagnosis, treatment, and research center in China. He has personally performed over 10,000 radical urological oncology surgeries, ranking first in the country (over 5,000 prostate cancer surgeries). He established the first cross-regional multidisciplinary diagnosis and treatment platform in China – the "China Urological Oncology MDT Consultation Platform".